Cas:878427-02-2 3-(2-fluorophenyl)-5-methyl-4H-1,2-oxazole-5-carboxylic acid manufacturer & supplier

Chemical Name:3-(2-fluorophenyl)-5-methyl-4H-1,2-oxazole-5-carboxylic acid

CAS.NO:878427-02-2

Synonyms:3-(2-fluorophenyl)-5-methyl-4H-1,2-oxazole-5-carboxylic acid

Molecular Formula:C₁₁H₁₀FNO₃

Molecular Weight:223.20000

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:58.89000

Exact Mass:223.06400

LogP:1.22900

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-(2-fluorophenyl)-5-methyl-4H-1,2-oxazole-5-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(2-fluorophenyl)-5-methyl-4H-1,2-oxazole-5-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(2-fluorophenyl)-5-methyl-4H-1,2-oxazole-5-carboxylic acid Use and application,3-(2-fluorophenyl)-5-methyl-4H-1,2-oxazole-5-carboxylic acid technical grade,usp/ep/jp grade.

Related News: “His strong track record of success and deep experience of fast-moving consumer goods and consumer health, proven at P&G, Novartis and GSK, means he is the right choice” to lead the consumer health unit as an independent company, GSK Chairman Jonanthan Symonds said of McNamara in the statement. 5-Amino-N-(1-methylcarbamoyl-2-phenyl-ethyl)-isophthalamic acid manufacturers the strategy lays out the challenges that researchers and institutions are facing, including skills shortages in particular disciplines, limited opportunities for career progression and issues of bullying and harassment. N-[(R)-2-hydroxy-1-phenylethyl]-4-phenyl-1,4-dihydroisoquinolin-3-one suppliers The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above, EMA said. Cyclo(L-alanyl-D-tryptophyl-L-asparaginyl-L-glutaminyl-L-tryptophyl-L-valyl-L-ornithyl-L-leucyl-D-phenylalanyl-L-prolyl) vendor & factory “His strong track record of success and deep experience of fast-moving consumer goods and consumer health, proven at P&G, Novartis and GSK, means he is the right choice” to lead the consumer health unit as an independent company, GSK Chairman Jonanthan Symonds said of McNamara in the statement.,It’s official. Nearly two years after the FDA granted conditional approval to Merck’s Keytruda and Eisai’s Lenvima for endometrial cancer, the U.S. regulator has blessed the combination therapy, with no strings attached.